OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S
Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 9, pp. 847-860
Open Access | Times Cited: 198
Jerald Sadoff, Glenda Gray, An Vandebosch, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 9, pp. 847-860
Open Access | Times Cited: 198
Showing 1-25 of 198 citing articles:
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 234
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 234
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
Wing Ying Au, Peter Pak‐Hang Cheung
BMJ (2022), pp. e069989-e069989
Open Access | Times Cited: 126
Wing Ying Au, Peter Pak‐Hang Cheung
BMJ (2022), pp. e069989-e069989
Open Access | Times Cited: 126
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 111
Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 111
Long COVID: An inevitable sequela of SARS-CoV-2 infection
Chih‐Cheng Lai, Chi‐Kuei Hsu, Muh‐Yong Yen, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 1, pp. 1-9
Open Access | Times Cited: 98
Chih‐Cheng Lai, Chi‐Kuei Hsu, Muh‐Yong Yen, et al.
Journal of Microbiology Immunology and Infection (2022) Vol. 56, Iss. 1, pp. 1-9
Open Access | Times Cited: 98
Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials
Zhirong Yang, Yi-Wen Jiang, Fu-Xiao Li, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 4, pp. e236-e246
Open Access | Times Cited: 89
Zhirong Yang, Yi-Wen Jiang, Fu-Xiao Li, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 4, pp. e236-e246
Open Access | Times Cited: 89
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
Youyi Fong, Adrian B. McDermott, David Benkeser, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 1996-2010
Open Access | Times Cited: 73
Youyi Fong, Adrian B. McDermott, David Benkeser, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 1996-2010
Open Access | Times Cited: 73
Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
Xiaodi Wu, Ke Xu, Ping Zhan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Xiaodi Wu, Ke Xu, Ping Zhan, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
Karin Hardt, An Vandebosch, Jerald Sadoff, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 12, pp. 1703-1715
Open Access | Times Cited: 63
Karin Hardt, An Vandebosch, Jerald Sadoff, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 12, pp. 1703-1715
Open Access | Times Cited: 63
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis
Weihao Shao, Xiaorui Chen, Caifang Zheng, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2383-2392
Open Access | Times Cited: 62
Weihao Shao, Xiaorui Chen, Caifang Zheng, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2383-2392
Open Access | Times Cited: 62
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, et al.
PLoS Medicine (2022) Vol. 19, Iss. 10, pp. e1003979-e1003979
Open Access | Times Cited: 39
Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, et al.
PLoS Medicine (2022) Vol. 19, Iss. 10, pp. e1003979-e1003979
Open Access | Times Cited: 39
A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults
Kun Xu, Zihan Wang, Maorong Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
Kun Xu, Zihan Wang, Maorong Qin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 29
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 29
Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?
Christine Stabell Benn, Frederik Schaltz-Buchholzer, Sebastian Nielsen, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106733-106733
Open Access | Times Cited: 25
Christine Stabell Benn, Frederik Schaltz-Buchholzer, Sebastian Nielsen, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106733-106733
Open Access | Times Cited: 25
Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion
Tabea M. Eser, Olga Baranov, Manuel Huth, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Tabea M. Eser, Olga Baranov, Manuel Huth, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine
Eddie Underwood, Lisa M. Dunkle, Shabir A. Madhi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 501-517
Open Access | Times Cited: 23
Eddie Underwood, Lisa M. Dunkle, Shabir A. Madhi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 501-517
Open Access | Times Cited: 23
Broad-spectrum pan-genus and pan-family virus vaccines
Chee Wah Tan, Sophie Valkenburg, Leo L. M. Poon, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 902-916
Open Access | Times Cited: 22
Chee Wah Tan, Sophie Valkenburg, Leo L. M. Poon, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 902-916
Open Access | Times Cited: 22
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 9
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 9
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 9
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 9
Incidence and management of the main serious adverse events reported after COVID ‐19 vaccination
Teresa Padilla‐Flores, Alicia Sampieri, Luis Vaca
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 9
Teresa Padilla‐Flores, Alicia Sampieri, Luis Vaca
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 9
A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines
Xiao‐Feng He, Jiao Su, Yunan Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Xiao‐Feng He, Jiao Su, Yunan Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
COVID-19 and vaccination: myths vs science
Vivek P. Chavda, Yangmin Chen, Jayant Dave, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1603-1620
Closed Access | Times Cited: 34
Vivek P. Chavda, Yangmin Chen, Jayant Dave, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1603-1620
Closed Access | Times Cited: 34
